# VYVANSE
> **NDA021977** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2007-02-23
## Drug
- **FDA Application Number:** NDA021977
- **Application type:** New Drug Application
- **Brand name:** VYVANSE
- **Generic name:** LISDEXAMFETAMINE DIMESYLATE
- **Active ingredients:** LISDEXAMFETAMINE DIMESYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS USA
- **Manufacturer:** Takeda Pharmaceuticals America, Inc.
- **First approval:** 2007-02-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021977)
---
*AI Analytics · CC0 1.0*